Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

YKL‐40 in giant cells and macrophages from patients with giant cell arteritis

YKL‐40 in giant cells and macrophages from patients with giant cell arteritis Objective YKL‐40, a mammalian member of the family 18 glycosyl hydrolases, is secreted by activated macrophages at a late stage of differentiation. Macrophages are present in inflammation of the arterial wall and are thought to participate in the pathogenesis of giant cell arteritis (GCA). The aim of this study was to evaluate whether macrophages and giant cells of patients with GCA produce YKL‐40, and whether serum YKL‐40 concentrations are elevated in these patients. Methods Serum YKL‐40 was determined by radioimmunoassay in 19 patients with GCA and 8 patients with polymyalgia rheumatica (PMR) who were followed up prospectively during 1 year of treatment with prednisolone. Immunohistochemical staining for YKL‐40 was performed in temporal artery biopsy samples that were obtained before treatment. Results In the arteritic vessels of patients with GCA, positive staining for the YKL‐40 antigen was found in CD68+ giant cells and mononuclear cells located in the media. Macrophages located in the adventitia and intima were negative for YKL‐40. At the time of diagnosis, patients with GCA had an increased median serum level of YKL‐40 (256 μg/liter; P < 0.01) compared with healthy age‐matched controls (median 118 μg/liter), and the serum level of YKL‐40 decreased to normal levels during prednisolone treatment (–38% after 1 month; P < 0.001). Most patients with PMR had normal serum YKL‐40 levels (median 158 μg/liter) and had no changes in the serum YKL‐40 levels during prednisolone treatment. The observed changes in serum YKL‐40 did not always parallel the changes in serum C‐reactive protein levels and erythrocyte sedimentation rate during the 1‐year study period. Conclusion YKL‐40 is found in CD68+ giant cells and mononuclear cells in the media of arteritic vessels of patients with GCA, and the concentration of serum YKL‐40 may reflect the local activity of these cells in the inflamed artery. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Arthritis & Rheumatism Wiley

YKL‐40 in giant cells and macrophages from patients with giant cell arteritis

Download PDF
7 pages

 
/lp/wiley/ykl-40-in-giant-cells-and-macrophages-from-patients-with-giant-cell-2glipc1Xl4

References (15)

Publisher
Wiley
Copyright
Copyright © 1999 by the American College of Rheumatology
ISSN
0004-3591
eISSN
1529-0131
DOI
10.1002/1529-0131(199912)42:12<2624::AID-ANR17>3.0.CO;2-K
pmid
10616010
Publisher site
See Article on Publisher Site

Abstract

Objective YKL‐40, a mammalian member of the family 18 glycosyl hydrolases, is secreted by activated macrophages at a late stage of differentiation. Macrophages are present in inflammation of the arterial wall and are thought to participate in the pathogenesis of giant cell arteritis (GCA). The aim of this study was to evaluate whether macrophages and giant cells of patients with GCA produce YKL‐40, and whether serum YKL‐40 concentrations are elevated in these patients. Methods Serum YKL‐40 was determined by radioimmunoassay in 19 patients with GCA and 8 patients with polymyalgia rheumatica (PMR) who were followed up prospectively during 1 year of treatment with prednisolone. Immunohistochemical staining for YKL‐40 was performed in temporal artery biopsy samples that were obtained before treatment. Results In the arteritic vessels of patients with GCA, positive staining for the YKL‐40 antigen was found in CD68+ giant cells and mononuclear cells located in the media. Macrophages located in the adventitia and intima were negative for YKL‐40. At the time of diagnosis, patients with GCA had an increased median serum level of YKL‐40 (256 μg/liter; P < 0.01) compared with healthy age‐matched controls (median 118 μg/liter), and the serum level of YKL‐40 decreased to normal levels during prednisolone treatment (–38% after 1 month; P < 0.001). Most patients with PMR had normal serum YKL‐40 levels (median 158 μg/liter) and had no changes in the serum YKL‐40 levels during prednisolone treatment. The observed changes in serum YKL‐40 did not always parallel the changes in serum C‐reactive protein levels and erythrocyte sedimentation rate during the 1‐year study period. Conclusion YKL‐40 is found in CD68+ giant cells and mononuclear cells in the media of arteritic vessels of patients with GCA, and the concentration of serum YKL‐40 may reflect the local activity of these cells in the inflamed artery.

Journal

Arthritis & Rheumatism – Wiley

Published: Dec 1, 1999

There are no references for this article.